Germline CNV Detection through Whole-Exome Sequencing (WES) Data Analysis Enhances Resolution of Rare Genetic Diseases
Genes · 21.07.2023 · 14 (7) · 1490
DOI: 10.3390/genes14071490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 21.07.2023. Verfasst von Faidon-Nikolaos Tilemis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics, St. Sophia's Children's Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greec…. Hauptthemen laut MEDLINE: Rare Diseases, Algorithms. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Whole-Exome Sequencing (WES) has proven valuable in the characterization of underlying genetic defects in most rare diseases (RDs). Copy Number Variants (CNVs) were initially thought to escape detection. Recent technological advances enabled CNV calling from WES data with the use of accurate and highly sensitive bioinformatic tools. Amongst 920 patients referred for WES, 454 unresolved cases were further analysed using the ExomeDepth algorithm. CNVs were called, evaluated and categorized according to ACMG/ClinGen recommendations. Causative CNVs were identified in 40 patients, increasing the diagnostic yield of WES from 50.7% (466/920) to 55% (506/920). Twenty-two CNVs were available for validation and were all confirmed; of these, five were novel. Implementation of the ExomeDepth tool promoted effective identification of phenotype-relevant and/or novel CNVs. Among the advantages of calling CNVs from WES data, characterization of complex genotypes comprising both CNVs and SNVs minimizes cost and time to final diagnosis, while allowing differentiation between true or false homozygosity, as well as compound heterozygosity of variants in AR genes. The use of a specific algorithm for calling CNVs from WES data enables ancillary detection of different types of causative genetic variants, making WES a critical first-tier diagnostic test for patients with RDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Medical Genetics, St. Sophia's Children's Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Research University Institute for the Study and Prevention of Genetic and Malignant Disease of Childhood, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Genetic Medicine and Development, Medical School, University of Geneva, 1211 Geneva, Switzerland.
- Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
ORCID-Profile: Nikolaos M Marinakis, Danai Veltra, Kyriaki Kekou, Joanne Traeger-Synodinos, Christalena Sofocleous
Zitieren
APA
Tilemis, F. N., Marinakis, N. M., Veltra, D., Svingou, M., Kekou, K., Mitrakos, A., Tzetis, M., Kosma, K., Makrythanasis, P., Traeger-Synodinos, J., & Sofocleous, C. (2023). Germline CNV Detection through Whole-Exome Sequencing (WES) Data Analysis Enhances Resolution of Rare Genetic Diseases. Genes, 14(7), 1490. https://doi.org/10.3390/genes14071490
Vancouver
Tilemis FN, Marinakis NM, Veltra D, Svingou M, Kekou K, Mitrakos A, et al. Germline CNV Detection through Whole-Exome Sequencing (WES) Data Analysis Enhances Resolution of Rare Genetic Diseases. Genes. 2023;14(7):1490. doi:10.3390/genes14071490
BibTeX
@article{Tilemis2023,
author = {Tilemis, Faidon-Nikolaos and Marinakis, Nikolaos M and Veltra, Danai and Svingou, Maria and Kekou, Kyriaki and Mitrakos, Anastasios and Tzetis, Maria and Kosma, Konstantina and Makrythanasis, Periklis and Traeger-Synodinos, Joanne and Sofocleous, Christalena},
title = {Germline CNV Detection through Whole-Exome Sequencing (WES) Data Analysis Enhances Resolution of Rare Genetic Diseases},
journal = {Genes},
year = {2023},
volume = {14},
number = {7},
pages = {1490},
doi = {10.3390/genes14071490}
}
EUVIMED